bioAffinity Technologies (BIAFW) Assets Average (2022 - 2026)

bioAffinity Technologies has disclosed Assets Average across 5 years of filings, most recently posting $9.5 million for Q1 2026.

• In Q1 2026, Assets Average rose 56.75% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 56.75% YoY), while the FY2025 annual figure was $8.7 million, up 18.59% from the prior year.
• Assets Average eased to $9.5 million in Q1 2026, from $11.3 million in the prior quarter.
• Over the last five years, Assets Average for BIAFW reached as high as $13.1 million in Q4 2022 and fell as low as $5.1 million in Q2 2025.
• The 5-year median for Assets Average is $8.7 million (2023), against an average of $8.7 million.
• Annual changes were most pronounced in 2024 — Assets Average sank 30.71% — and 2025, when it jumped 72.26%.
• A 5-year view of Assets Average shows it stood at $13.1 million in 2022, then dropped by 29.85% to $9.2 million in 2023, then slipped by 29.03% to $6.5 million in 2024, then soared by 72.26% to $11.3 million in 2025, then dropped by 16.0% to $9.5 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $9.5 million, $11.3 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.